Cite
Psychosocial Effects of Receiving Genome-Wide Polygenic Risk Information Concerning Type 2 Diabetes and Coronary Heart Disease: A Randomized Controlled Trial.
MLA
Halmesvaara, Otto, et al. “Psychosocial Effects of Receiving Genome-Wide Polygenic Risk Information Concerning Type 2 Diabetes and Coronary Heart Disease: A Randomized Controlled Trial.” Frontiers in Genetics, vol. 13, May 2022, pp. 1–14. EBSCOhost, https://doi.org/10.3389/fgene.2022.881349.
APA
Halmesvaara, O., Vornanen, M., Kääriäinen, H., Perola, M., Kristiansson, K., & Konttinen, H. (2022). Psychosocial Effects of Receiving Genome-Wide Polygenic Risk Information Concerning Type 2 Diabetes and Coronary Heart Disease: A Randomized Controlled Trial. Frontiers in Genetics, 13, 1–14. https://doi.org/10.3389/fgene.2022.881349
Chicago
Halmesvaara, Otto, Marleena Vornanen, Helena Kääriäinen, Markus Perola, Kati Kristiansson, and Hanna Konttinen. 2022. “Psychosocial Effects of Receiving Genome-Wide Polygenic Risk Information Concerning Type 2 Diabetes and Coronary Heart Disease: A Randomized Controlled Trial.” Frontiers in Genetics 13 (May): 1–14. doi:10.3389/fgene.2022.881349.